USA flag logo/image

An Official Website of the United States Government

Company Information:

Name: PharmaSeq, Inc.
Address: 11 Deer Park Dr.
Suite 104
Monmouth Jct., NJ 08852-1923
Located in HUBZone: No
Woman-Owned: No
Minority-Owned: No
URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $2,165,595.00 13
SBIR Phase II $8,912,479.00 7

Award List:

MULTIPLEX DNA DIAGNOSTIC ASSAY ON MICROTRANSPONDERS

Award Year / Program / Phase: 1998 / SBIR / Phase I
Agency: HHS
Principal Investigator: Mandecki, Wlodek
Award Amount: $100,000.00

N/A

Award Year / Program / Phase: 1999 / SBIR / Phase II
Agency: HHS
Principal Investigator: Mandecki Wlodek
Award Amount: $719,392.00

Rapid Cystic Fibrosis DNA Mutation Screening Test

Award Year / Program / Phase: 2003 / SBIR / Phase I
Agency: HHS
Principal Investigator: Wlodek Mandecki
Award Amount: $100,000.00
Abstract:
DESCRIPTION (provided by applicant): Cystic fibrosis (CF) is a highly morbid, autosomal recessive disease caused by one or more mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The CFTR protein is important in transporting sodium and chloride… More

Flow instrument for two-color assays on microtransponder

Award Year / Program / Phase: 2004 / SBIR / Phase I
Agency: HHS
Principal Investigator: Wlodek Mandecki
Award Amount: $127,545.00
Abstract:
DESCRIPTION (provided by applicant): PharmaSeq provides ultra-small microtransponders and a fluidics-based, bench-top flow reader as tools to perform complex bioassays. The assay involves three phases: conjugation or synthesis of probe molecules on the microtransponder surface, the binding reaction… More

Cell-based Assay on Microtransponders

Award Year / Program / Phase: 2004 / SBIR / Phase I
Agency: HHS
Principal Investigator: Wlodek Mandecki
Award Amount: $100,000.00
Abstract:
DESCRIPTION (provided by applicant): It is proposed to develop a multiplex cytotoxicity assay on electronic microchips, microtransponders. Each microtransponder is composed of photocells, antenna and memory to store information that identifies the specific features of the biological material,… More

Fluidic Sorter for Microtransponders

Award Year / Program / Phase: 2005 / SBIR / Phase I
Agency: HHS
Principal Investigator: Wlodek Mandecki
Award Amount: $100,000.00
Abstract:
DESCRIPTION (provided by applicant): We propose to develop a fluidics-based automated sorter for microtransponders to complement the existing line of PharmaSeq instruments and reagents. PharmaSeq provides ultra-small light-powered microtransponders and a fluidics-based bench-top flow reader as tools… More

Flow Instrument for Two-color Assay on Microtransponders

Award Year / Program / Phase: 2006 / SBIR / Phase II
Agency: HHS
Principal Investigator: Wlodek Mandecki
Award Amount: $746,326.00
Abstract:
DESCRIPTION (provided by applicant): PharmaSeq provides ultra-small micro transponders and a fluidics-based, bench-top flow reader as tools to perform complex bioassays. A micro transponder is an integrated circuit with an electronically stored ID (64 bits) and the capability to transmit the ID by… More

Rapid Cystic Fibrosis Mutation Screening Test

Award Year / Program / Phase: 2008 / SBIR / Phase II
Agency: HHS
Principal Investigator: Wlodek Mandecki
Award Amount: $2,997,635.00
Abstract:
DESCRIPTION (provided by applicant): We propose to conduct a clinical study of an in vitro diagnostic system capable of detecting mutations in the gene related to cystic fibrosis (CFTR). The system consists of the cystic fibrosis DNA-based assay and suppo rting instrumentation. The assay was… More

Use of Silver Nanostructures on Microtransponders in Ultra-sensitive Assay

Award Year / Program / Phase: 2008 / SBIR / Phase I
Agency: HHS
Principal Investigator:
Award Amount: $298,430.00
Abstract:
DESCRIPTION (provided by applicant): The main goal of the project is to increase sensitivity of the microtransponder-based multiplexed bioassays by (1) introducing a coating with silver nanostructures onto the microtransponders (MTPs) to enhance fluorescen ce, and (2) improving the fluorescence… More

SBIR PHASE I ANTIBODY ARRAY FOR CANCER DETECTION (TOPIC236)

Award Year / Program / Phase: 2008 / SBIR / Phase I
Agency: HHS
Principal Investigator: Wlodek Mandecki
Award Amount: $150,000.00
Abstract:
This Phase I project aims to develop a technology to simultaneously measure three biomarkders for early prostate cancer detection using an electronic radio frequency (RF) light-powered microtransponder. Antigens will be captured using antibodies coupled to the microtransponders and detected using… More

Tagging of Laboratory Mice with Microtransponders

Award Year / Program / Phase: 2009 / SBIR / Phase I
Agency: HHS
Principal Investigator: Wlodek Mandecki
Award Amount: $117,362.00
Abstract:
DESCRIPTION (provided by applicant): The purpose of the present project is to develop a new type of RFID tagging system for tracking laboratory mice. It is based on the PharmaSeq laser light-powered microtransponder. Its major advantages are its small size (500 5m x 500 5m x 100 5m), monolithic… More

Use of silver nanostructures on microtransponders in ultra-sensitive assay

Award Year / Program / Phase: 2010 / SBIR / Phase II
Agency: HHS
Principal Investigator: Wlodek Mandecki
Award Amount: $1,252,912.00
Abstract:
DESCRIPTION (provided by applicant): The main goal of the project is to increase the sensitivity of microtransponder-based multiplexed bioassays by (1) introducing a coating with silver nanostructures onto the microtransponders (MTPs) to enhance fluorescen ce emission, and (2) improving the… More

Tagging of Laboratory Mice with Microtransponders

Award Year / Program / Phase: 2010 / SBIR / Phase II
Agency: HHS
Principal Investigator: Wlodek Mandecki
Award Amount: $1,112,308.00
Abstract:
DESCRIPTION (provided by applicant): The purpose of the present project is to develop a new type of RFID tagging system for tracking mice. It is based on the PharmaSeq laser light-activated microtransponder, also known as p-Chip . Its major advantages are its small size (500 5m x 500 5m x 100 5m),… More

Tagging of Histopathology Specimens with Light-Activated RFID Chips

Award Year / Program / Phase: 2011 / SBIR / Phase I
Agency: HHS
Principal Investigator: Wlodek Mandecki – 732-355-0100
Award Amount: $150,000.00
Abstract:
DESCRIPTION (provided by applicant): The purpose of the present project is to demonstrate the feasibility of using a novel RFID chip to tag and track tissue cassettes and glass slides that are used in histopathology laboratories. The system is based on thePharmaSeq laser light-activated… More

Tagging of Histopathology Specimens with Light-Activated RFID p-Chips

Award Year / Program / Phase: 2012 / SBIR / Phase II
Agency: HHS
Principal Investigator: Wlodek Mandecki – 732-355-0100
Award Amount: $1,172,636.00
Abstract:
DESCRIPTION (provided by applicant): The purpose of the present project is to develop and validate the use of ultra-small RFID chips to tag and track tissue cassettes and glass slides that are used in histopathology laboratories. The system is based on thePharmaSeq laser light-activated… More

Characterization of antitumor auto-antibodies using combinatorial peptide librari

Award Year / Program / Phase: 2012 / SBIR / Phase I
Agency: HHS
Principal Investigator: Wlodek Mandecki – 732-355-0100
Award Amount: $272,360.00
Abstract:
DESCRIPTION (provided by applicant): The development of circulating auto-antibodies to tumor-associated antigens (TAAs) has been observed at early cancer stages. TAA auto-antibodies are attractive as diagnostic markers because they are stable and persistent in cancerous conditions yet minimally… More

Light-activated Electronic p-Chips for Tagging Samples in Biorepositories and Cry

Award Year / Program / Phase: 2012 / SBIR / Phase I
Agency: HHS
Principal Investigator: Wlodek Mandecki – 732-355-0100
Award Amount: $300,000.00
Abstract:
DESCRIPTION (provided by applicant): The purpose of the present project is to implement a new RFID tagging system for rapid identification of vials in biorepositories. It is based on the PharmaSeq laser light- activated microtransponder, which is also known as a p-Chip. Its main advantages are its… More

IGF::OT::IGF OTHER FUNCTIONS PHARMASEQ PHASE I, TOPIC 309, MULTIPLEX PROSTATE CANCER SERUM ASSAY ON RFID P-CHIPS

Award Year / Program / Phase: 2012 / SBIR / Phase I
Agency: HHS
Principal Investigator: Wlodek Mandecki – 732-355-0100
Award Amount: $199,909.00
Abstract:
The project is aimed at the development of a cost effective, serum-based multiplex assay for early detection of clinically significant forms of prostate cancer. The assay utilizes metal-enhanced flourescence to provide an ultra-sensitive immunoassay for three cancer markers: alpha-methylacyl… More

Light-activated Electronic p-Chips for Tagging Samples in Biorepositories and Cry

Award Year / Program / Phase: 2013 / SBIR / Phase II
Agency: HHS
Principal Investigator: Wlodek Mandecki – 732-355-0100
Award Amount: $911,270.00
Abstract:
DESCRIPTION (provided by applicant): The purpose of the present project is to implement a new RFID tagging system for rapid identification of vials in biorepositories. It is based on the PharmaSeq laser light- activated microtransponder, which is also known as a p-Chip. Its main advantages are its… More

SBIR Phase I: A Radio p-Chip for intracellular sensing and communication

Award Year / Program / Phase: 2013 / SBIR / Phase I
Agency: NSF
Principal Investigator: Wlodek Mandecki
Award Amount: $149,989.00
Abstract:
This Small Business Innovation Research (SBIR) Phase I project aims at developing a Radio p-Chip, the first microchip with a sensor that can be injected into live cells, and transmit information from within without a physical connection. The design combines elements of laser light-activation of the… More